Inactive Instrument

Sector Chart Carbylan Therapeutics Inc Nasdaq

Equities

US1413841073

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Biopharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
91.94B
38.74B
32.82B
26.66B
15.32B
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW